Body mass index–associated differences in response to ovulation induction with letrozole

Objective To compare occurrence of pregnancy among obese (body mass index [BMI] ≥30) and nonobese (BMI

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Fertility and sterility 2011-11, Vol.96 (5), p.1206-1208
Hauptverfasser:	McKnight, Katherine K., M.D, Nodler, James L., M.D, Cooper, John J., M.D, Chapman, Victoria R., M.P.H., B.S.N, Cliver, Suzanne P., B.A, Bates, Gordon Wright, M.D
Format:	Artikel
Sprache:	eng
Schlagworte:	abortion (animals) Adult Alabama aromatase inhibitor Aromatase Inhibitors - therapeutic use Biological and medical sciences Birth control Body Mass Index Chi-Square Distribution cohort studies conception confidence interval Female Fertility Agents, Female - therapeutic use Gynecology. Andrology. Obstetrics Humans Infertility, Female - complications Infertility, Female - physiopathology Infertility, Female - therapy insemination Insemination, Artificial Internal Medicine intrauterine insemination Letrozole Logistic Models luteinizing hormone Medical sciences menstrual cycle multiple births Nitriles - therapeutic use Obesity - complications Obesity - physiopathology Obstetrics and Gynecology Odds Ratio Ovary - drug effects Ovary - physiopathology ovulation Ovulation - drug effects ovulation induction Ovulation Induction - methods patients Pregnancy pregnancy outcome Pregnancy Rate Retrospective Studies Sterility. Assisted procreation Treatment Outcome Triazoles - therapeutic use unspecific monooxygenase women
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Objective To compare occurrence of pregnancy among obese (body mass index [BMI] ≥30) and nonobese (BMI
ISSN:	0015-0282 1556-5653
DOI:	10.1016/j.fertnstert.2011.08.002